Data from public SEC 13F & STOCK Act filings, delayed up to ~45 days, partial holdings only — for research, not investment advice.
ASND
ASCENDIS PHARMA A/SData as of 2026 Q1 (03-31) · 13F snapshot
Summary
ASCENDIS PHARMA A/S (ASND) is held by 7 tracked hedge-fund managers, a combined reported value of ~$560.23M; the largest are Stephen Mandel, Ken Griffin, Steven Cohen. This quarter: 1 new, 1 trimmed, 1 closed. 17 members of Congress have disclosed STOCK Act trades. Data as of 2026 Q1, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Quiet
Gurus holding7
Congress trades17
Price$218.06vs quarter-end-4.66%
Sectors0
This quarter's moves
Top holderStephen MandelNew1
Added0
Trimmed / sold2
Stephen MandelHold
Value $229.04M0.8% of portfolio1,436,9812021 Q3
Value $24.74M0.8% of portfolio158,7202025 Q1
George SorosAdd
Value $13.64M0.4% of portfolio100,0002024 Q2
Value $13.17M— of portfolio57,6002026 Q1
Value $3.98M— of portfolio20,0002025 Q3
Value $2.29M— of portfolio10,0002026 Q1
Value $1.78M— of portfolio20,0002023 Q2
Value $1.49M— of portfolio7,5002025 Q3
Value $533.1K— of portfolio2,5002025 Q4
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Stephen Mandel | $229.04M | 0.8% | Hold |
| Stanley Druckenmiller | $24.74M | 0.8% | Trim |
| George Soros | $13.64M | 0.4% | Add |
| Ken GriffinCALL | $13.17M | — | — |
| Izzy EnglanderPUT | $3.98M | — | — |
| Ken GriffinPUT | $2.29M | — | — |
| Steven CohenPUT | $1.78M | — | — |
| Steven CohenCALL | $1.49M | — | — |
| Izzy EnglanderCALL | $533.1K | — | — |